Published: May 7th 2024 | Updated: May 21st 2024
FDA accepts BLA for subcutaneous nivolumab in solid tumors
Published: October 31st 2024 | Updated: November 4th 2024
TYRA-300 shows encouraging safety, efficacy in FGFR3+ metastatic urothelial carcinoma
Published: October 28th 2024 | Updated: November 4th 2024
Vaginal estrogen for GSM not associated with major adverse cardiovascular events
Published: October 25th 2024 | Updated: November 4th 2024
OASIS: Efficacy of Revi System for urgency incontinence maintained at 2 years
Published: July 29th 2024 | Updated: November 4th 2024
Study highlights need for improved enrollment, reporting in urolithiasis trials
Published: July 10th 2024 | Updated: November 4th 2024
AUA, GURS, SUFU amend guideline for incontinence after prostate treatment